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Abstract
Aims: Increased oxidative stress and mitochondrial dysfunction in obese adipocytes contribute to adipokine
dysregulation, inflammation, and insulin resistance. Results: Through an advanced proteomic analysis, we
found that peroxiredoxin 3 (Prx3), a thioredoxin-dependent mitochondrial peroxidase, is highly expressed in
3T3-L1 adipocytes compared to preadipocytes. Interestingly, in obese db/db mice and human subjects, adipose
Prx3 levels were significantly decreased, indicating its association with obesity. We therefore employed Prx3
knockout (KO) mice and transfected 3T3-L1 cells to examine the role of endogenous Prx3 in adipocyte metab-
olism. Prx3 KO mice had increased fat mass compared to wild-type due to adipocyte hypertrophy. Increased
adipogenic transcription factors and lipogenic gene expression during differentiation of adipose tissue-derived
stem cells from Prx3-deficient mice confirmed that these adipocytes are likely to accumulate fat. Mitochondrial
protein carbonylation in Prx3 KO adipose tissue and mitochondrial superoxide level in Prx3 knockdown 3T3-L1
cells were increased showing aberrant regulation of oxidative stress. Proteomic analysis and gene expression
analysis of Prx3 KO mice adipocytes also showed defect in mitochondria biogenesis along with enzymes in-
volved in glucose/lipid metabolism and oxidative phosphorylation. In addition, expression level of adiponectin
was downregulated and plasminogen activator inhibitor-1 was upregulated in Prx3 KO adipocytes. Impaired
glucose tolerance and insulin resistance further implied metabolic dysregulation in Prx3 KO mice. Innovation
and Conclusion: These data suggest that endogenous Prx3 may play an essential role in maintaining normal
characteristics of adipocytes and that defect in Prx3 alters mitochondrial redox state and function, and adipokine
expression in adipocytes leading to metabolic alteration. Antioxid. Redox Signal. 16, 229–243.
Introduction
Obesity is one of the most prevalent chronic diseasesworldwide (37). Obesity is defined as excessive fat accu-
mulation in the adipose tissue that evokes a cluster of diseases
such as insulin resistance, type 2 diabetes mellitus, and cardio-
vascular diseases referred to as ‘metabolic syndrome’ (39). Recent
studies have implicated systemic oxidative stress as a major
contributing factor for obesity-related metabolic complications
(20) and that oxidative stress in adipose tissue results in inflam-
mation, adipokine dysregulation, and insulin resistance (10, 16).
Since adipose tissue plays a crucial role in regulatingwhole body
insulin sensitivity (3), a balanced regulation of pro-oxidative and
antioxidative mechanism in adipocytes is an important matter.
Adipocytes are the primary cells that compose adipose
tissue, and these cells function in maintaining energy ho-
meostasis by buffering lipid metabolites and secreting adi-
Innovation
Accumulating evidence indicates that adipocyte oxi-
dative stress plays an important role in development of
obesity-related complications. However, adipocyte anti-
oxidant mechanism and its control are poorly understood.
The present study has identified Prx3, a thioredoxin-
dependent mitochondrial antioxidant, as a new target for
regulating adipocyte function, including adipokine ex-
pression, and glucose/lipid metabolism through diverse
measures, including proteomics and employing Prx3 KO
mice, adipocyte-derived stem cells isolated from Prx3 KO
mice, and 3T3-L1 adipogenic model. Importantly, de-
creased Prx3 expression in peri-renal adipose tissue of
overweight subjects provides a possible clinical implica-
tion on the role of adipocyte Prx3 in metabolic syndrome.
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pokines such as leptin, adiponectin, and plasminogen acti-
vator inhibitor-1 (PAI-1). Dysregulation of adipokine pro-
duction affects the function of peripheral tissues, including
liver and muscle, which increases the risk of metabolic com-
plications (38). Therefore, a thorough understanding of adi-
pocyte differentiation, expansion, and its endocrine function
is necessary for developing therapies against obesity.
Proteomics have been widely applied recently for high-
throughput analysis of proteins. Up to date, few investiga-
tions have attempted to characterize the proteins that change
during adipogenesis (1, 2, 7, 21, 40) or those secreted from
adipocytes (24, 42). However, the methodologies had limita-
tions in detecting differences without gel separation and
identifying proteins with low resolution ion trap MS. In this
study, we employed an advanced proteomic methodology to
detect the changes in protein expression profiles during dif-
ferentiation of 3T3-L1 cells, a common in vitro model for
studying adipogenesis (11).
Our novel finding is that peroxiredoxin 3 (Prx3) exists abun-
dantly in mature 3T3-L1 adipocytes compared to preadipocytes
and is reduced in fat tissues of obese mice and human subjects.
Prxs are a family of cellular thiol peroxidases scavenging per-
oxides. Among six distinct members, Prx3 is unique in that it is
exclusively localized in the mitochondria (8). Studies have re-
ported that Prx3 knockout (KO) mice are hypersensitive to li-
popolysaccharide-induced lung inflammation (30) and that
overexpression of Prx3 has protective effects in neurons (13) and
myocardial infarction (31). The role of endogenous Prx3 in adi-
pocytes, however, has not been demonstrated.
Mitochondria are major source of cellular oxidative stress,
and ‘mitochondrial fitness’ plays a crucial role in the main-
tenance of adipocyte function (9). Since Prx3 is a mitochon-
drial antioxidant, our study focused on the role of
endogenous Prx3 linking mitochondrial oxidative stress and
regulation of adipocyte function. We found that Prx3-
deficient mice displayed increased fat mass. Adipose tissue-
derived stem cells from Prx3 KO mice and Prx3 knockdown
3T3-L1 adipocytes expressed higher levels of adipogenic
genes. Furthermore, increased mitochondrial oxidative stress
as well as downregulation in mitochondrial metabolic pro-
teins was observed in Prx3-deficient adipocytes. These adi-
pocytes also showed adipokine dysregulation, impaired
glucose tolerance and insulin sensitivity, all of which suggest
that Prx3 plays an essential role in maintaining adipose tissue
integrity and sustaining whole body metabolism.
Results
Comparative proteomic analysis of 3T3-L1
preadipocytes and mature adipocytes reveals
major changes in mitochondrial proteins related
to metabolism
Protein profiles of 3T3-L1 preadipocytes and mature adi-
pocyteswere compared by proteomic analysis (Supplementary
Fig. S1; Supplementary Data are available online at www.lie-
bertonline.com/ars). Among 57 protein spots that showed
significant changes (> 1.5-fold) between preadipocytes and
mature adipocytes (Supplementary Tables S1A and S1B), 16
proteins were significantly ( p< 0.05) upregulated and 6 pro-
teins downregulated in mature adipocytes (Table 1). The
identified proteins were classified and grouped based on their
known functions using gene ontology (www.godatabase.org,
accessed June 2010, Supplementary Fig. S2). More than 50% of
the identified proteins function in cellular metabolism, while
proteasome, chaperone, oxido-reduction, and transporter/
channel related proteins each comprise about 10% of total
identified proteins. Cellular location showed that mitochon-
drial proteins account for 38% of identified proteins, nearly
equivalent to cytosolic proteins.
Mitochondrial biogenesis is a fundamental aspect of adi-
pocyte differentiation (41). In our data, mitochondrial pro-
teins were all significantly increased in mature adipocytes.
Mitochondrial biogenesis was confirmed by increased mRNA
expression of mitochondrial transcription factor A (mtTFA)
and PPARc coactivator-1 alpha (PGC1a) and MitoTracker
staining (Supplementary Fig. S3).
Prx3 is highly expressed in mature adipocytes
and decreased in obese mice and human subjects
Proteomic analysis has revealed that mitochondrial specific
antioxidant Prx3 is dramatically upregulated during adipo-
genesis (Fig. 1A). The mRNA and protein expression exam-
ined at day 0, 2, 4, and 6 of differentiation showed a gradual
increase in Prx3 expression. Compared to Prx3, cytoplasmic
Prx1 and cytoplasmic/mitochondrial Prx5 levels were in-
creased to a lesser extent, indicating importance of Prx3 in
mature adipocytes (Figs. 1B and 1C).
Interestingly, mRNA and protein expression of Prx3 in
white adipose tissues (WAT) of db/db mice was greatly de-
creased compared to db/m mice (Figs. 1E and 1F), whereas in
liver and kidney Prx3 protein levels were significantly in-
creased (Supplementary Fig. S4). Concurrently, results from
human peri-renal WAT showed significantly decreased Prx3
mRNA expression in subjects with body mass index (BMI)
higher than 25 (Fig. 1G). In line with our result, association
between genetic variations of Prx3 and obesity risk has been
recently reported (14). Also, glutathione peroxidase 3 (GPx3),
which tended to decrease in our data, is substantially dimin-
ished in obese human subjects (BMI > 30) which is linked with
increased local and systemic oxidative stress (26). These re-
sults suggest a novel finding that decreased expression of
Prx3 is closely associated with obesity.
Prx3 KO mice display larger fat pads
with hypertrophied adipocytes
Since reactive oxygen species (ROS) produced by mito-
chondria are implicated in development of metabolic diseases
(9, 33), Prx3 may play a protective role in regulating adipo-
cytes. The body weights of wild-type (WT) and Prx3 KOmice
were indistinguishable at the 4-month period. However, by 20
months of age, the body weights of Prx3 KOmice were higher
than that of WT. A comparison of organ weights revealed a
significant increase in epididymal WAT (Fig. 2A). Morphol-
ogy and quantitative analysis further indicated that adipo-
cytes were larger in Prx3 KO mice (Figs. 2D and 2E).
Adipogenic genes are increased in Prx3-deficient
adipocytes and decreased in Prx3
overexpressed adipocytes
ROS production increases during differentiation of 3T3-L1
cells (10), likely due to increase in metabolic activity of the cell
required for lipid accumulation and excessive ROS stimulate
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adipogenesis (15, 25). It can therefore be translated that in-
crease in Prx3 is an adaptive response for fine adjustment of
ROS levels during adipogenesis. To evaluate the role of Prx3
on adipogenesis, we compared the adipocyte differentiation
capacity of adipose tissue-derived stem cells (ASCs) isolated
from WT and Prx3 KO mice. Rosiglitazone-induced differ-
entiation of ASCs showed dramatic accumulation of lipids,
but we used conventional differentiation medium with
3-isobutyl-1-methylxanthine (IBMX) instead, since rosiglita-
zone is a PPARc activator that forces preadipocytes to dif-
ferentiate. Although little difference was detected by Oil Red
O staining, possibly due to overall low differentiation rate,
expression of aP2, C/EBPa, and PPARc, the transcriptional
factors regulating adipocyte differentiation, were significantly
upregulated in differentiated ASCs from Prx3 KO mice com-
pared toWT (Figs. 3A and 3B). Consistently, increasedmRNA
expression of adipophilin and fatty acid synthase (FAS)
showed that Prx3 deficiency increases adipogenicity. Con-
versely, mitochondrial DNA (mtDNA) and PGC1a mRNA
expressions were downregulated in Prx3 KO ASCs, implying
Table 1. Differentially Expressed Proteins in Mature 3T3-L1 Adipocytes
No. P value
Ratio
(Adipo/3T3) Score %Cov. Mr pI
Accession
No. Symbol Protein Name
Cellular
Component
Proteins that function in metabolism
8 0.00283 - 2.3 1.42E+ 03 26 39503 5.0 Q9JHJ0 TMOD3 Tropomodulin-3 Cyto, CK
10 0.0445 - 2.0 649 43 28785.1 4.7 P17918 PCNA Proliferating cell
nuclear antigen;Cyclin
Nu
13 0.0476 - 1.5 7.87E+ 03 40 20678.6 5.3 Q9CPU0 LGUL Lactoylglutathione lyase
19 0.0097 2.6 2.40E+ 17 40 129685.7 6.3 Q05920 PYC Pyruvate carboxylase,
mitochondrial precursor
Mito
20 0.0223 2.5 1.01E+ 11 31 129685.7 6.3 Q05920 PYC Pyruvate carboxylase,
mitochondrial precursor
Mito
28 0.0267 2.7 6.46E+ 03 24 47874.5 8.0 Q9DBL1 ACDSB Acyl-CoA dehydrogenase,
short/branched chain
specific, mitochondrial
precursor
Mito
29 0.000722 2.1 6.52E+ 05 36 43232.1 8.5 P35486 ODPA Pyruvate dehydrogenase
E1 component alpha
subunit, somatic form,
mitochondrial precursor
Mito
30 0.0157 2.1 4.37E+ 03 23 102536.1 5.8 O08528 HXK2 Hexokinase type II Mito
35 0.0496 1.6 4.89E+ 05 41 36346.3 6.2 P14152 MDHC Malate dehydrogenase,
cytoplasmic
Cyto
38 0.0114 3.2 3.07E+ 04 41 32667.4 5.4 Q9D819 IPYR Inorganic pyrophosphatase Cyto
42 0.0332 1.5 1.22E+ 05 59 29820.3 5.0 P67778 PHB Prohibitin Memb
45 7.98E-06 2.3 9.31E+ 03 42 26000 6.1 P47968 RPIA Ribose-5-phosphate
isomerase
Proteins that relate with proteasome
3 0.0138 - 1.8 4.21E+ 10 38 80752.3 5.4 Q9QUR6 PPCE Prolyl endopeptidase Cyto
24 0.00189 2.4 6.93E+ 03 16 61977 4.9 Q8R317 UBQL1 Ubiquilin 1 Cyto, Nu,
Proteasome
Proteins that act as transporter/channel
40 0.0124 2.0 1.05E+ 07 48 32892.3 6.1 Q99J99 THTM 3-mercaptopyruvate
sulfurtransferase
Cyto, Mito
50 0.00779 2.1 5.57E+ 05 65 18618.4 5.5 Q9DCX2 ATP5H ATP synthase D chain,
mitochondrial
Mito
Proteins that act in oxido-reduction
41 0.00981 1.6 2.50E+ 08 65 35440.3 8.4 Q99L13 3HIDH 3-hydroxyisobutyrate
dehydrogenase,
mitochondrial precursor
Mito
47 0.000177 4.0 120 24 28109 7.2 P20108 PRDX3 Thioredoxin-dependent
peroxide reductase,
mitochondrial precursor
Mito
49 0.000176 2.1 3.35E+ 04 56 28127.3 7.2 P20108 PRDX3 Thioredoxin-dependent
peroxide reductase,
mitochondrial precursor
Mito
53 0.044 1.9 2.78E+ 03 43 15811.6 6.0 P08228 SODC Superoxide dismutase
[Cu-Zn]
Cyto
Unknown
9 0.024 - 1.7 5.72E+ 09 59 35752.7 4.8 P48036 ANXA5 Annexin A5
11 0.0003 - 2.0 4.77E+ 04 30 37280.2 5.6 P10605 CATB Cathepsin B precursor Lys
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that Prx3 is needed in the normal adipogenic process that
includes a massive mitochondrial biogenesis. Data from siR-
NA-transfected 3T3-L1 cells confirmed that knockdown of
endogenous Prx3 at day 0, 2, and 4 after induction of differ-
entiation increased aP2, C/EBPa, and PPARc expressions
compared to scrambled siRNA-transfected adipocytes (Fig.
3D), whereas Prx3 overexpression induced opposite effect
(Fig. 3E). These results indicate that deficiency in Prx3 in-
creases the potential of preadipocytes to differentiate and
accumulate lipids which may lead to increased fat mass in
Prx3 KO mice.
Comparative proteomic analysis of Prx3 KO
adipocytes shows dramatic decrease
in mitochondrial proteins
To further validate the role of Prx3 in adipocytes, we again
performed proteomic analysis with adipocytes isolated from
FIG. 1. Prx3 levels are increased during adipogenesis and decreased in white adipose tissues of obese mice and human
subjects. Prx3 levels in preadipocytes and mature adipocytes were evaluated by (A) proteomic analysis; (B) Western blot
analysis. (C) real-time PCR analysis of Prx1, 3, and 5 during adipogenesis. (D)MnSOD and hsp60 mRNA levels are shown as
a comparison. (E) mRNA levels of Prx3 and mtDNA and (F) protein levels of Prx3 in db/m and db/db mice white adipose
tissues. (G)mRNA levels of Prx3, GPx3, and mtDNA were measured by real-time PCR in 28 human peri-renal white adipose
tissues. Quantifications were normalized to 18S in each reaction, and to mtDNA or tubulin where indicated. Values are
means – SE. *p < 0.05 vs. db/m or BMI < 25. BMI, body mass index.
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epididymal WAT of WT and Prx3 KOmice. Among proteins
that differed between the two groups (Fig. 4), 10 proteins
significantly increased and 16 proteins decreased (Table 2).
Interestingly, the majority of proteins which decreased in
Prx3 KO mice were mitochondrial proteins mainly involved
in oxidative phosphorylation and fatty acid metabolism,
including ATP synthase subunit d (ATP5H) which is im-
portant for producing energy; NADH-ubiquinone oxidore-
ductase (NDUS1) working in respiratory electron transport;
dihydrolipoyllysine-residue acetyltransferase component
(ODP2) as a component of pyruvate dehydrogenase com-
plex; dienoyl-CoA isomerase (ECH1) involved in fatty acid
metabolism; and 3-hydroxyisobutyrate dehydrogenase
(3HIDH) as an enzyme to generate acetoacetate in fatty acid
synthesis.
Mitochondrial biogenesis, lipid metabolism,
and antioxidant systems are impaired in Prx3 KO
mice adipocytes
Consistent with Prx3 KO ASCs, mtDNA was significantly
reduced in Prx3 KO adipocytes compared to WT (Fig. 5A).
PGC1a and nuclear respiratory factor 1 (Nrf1), genes re-
sponsible for mitochondrial biogenesis, tended to be down-
regulated in Prx3 KO adipocytes. Immunostaining of WAT
showed that mitochondrial marker heat shock protein 60
(hsp60) was decreased in Prx3 KO mice (Fig. 5B). As previ-
ously reported in ob/ob mice (32), C/EBPa and PPARc were
significantly downregulated in Prx3 KO adipocytes as well as
db/dbmice (Supplementary Fig. S5), which could be explained
that in these terminally differentiated fat cells, some degree of
dedifferentiation has occurred.
Gene expressions of antioxidant enzymes showed that
manganese superoxide dismutase (MnSOD) and heme oxy-
genase-1 (HO-1) were significantly downregulated in Prx3
KO adipocytes. NAD(P)H: quinone oxidoreductase 1
(NQO1), a downstream target of nuclear factor E2-related
factor 2 (Nrf2), was also significantly downregulated. Plasma
thiobarbituric acid reactive substances (TBARS) levels and
nitrotyrosine staining in WAT confirmed increased oxidative
stress in Prx3 KO mice (Fig. 5C and 5D).
Lipid metabolism related gene expression showed that
FAS, lipoprotein lipase (Lpl), and hormone-sensitive lipase
(HSL) levels were upregulated, suggesting that overall lipid
metabolism is increased in Prx3 KO adipocytes. Conversely,
mRNA levels of medium-chain acyl-CoA dehydrogenase
(MCAD) and carnitine palmitoyl transferase 1a (CPT1a), mi-
tochondrial enzymes involved in fatty acid oxidation, were
downregulated, indicating that Prx3 KO adipocytes lack their
ability to burn excessive fat. Taken together with the pro-
teomics data, metabolic enzymes are impaired in Prx3 KO
mice adipocytes and as a result fatty acids are likely to accu-
mulate in WAT.
FIG. 2. Prx3 KO mice have larger amounts of adipose tissue compared to WT mice. (A) Body weight and organ weight of
4- and 20-month-old WT and Prx3 KO mice are shown. (B and C) Representative pictures of WT and Prx3 KO mice
epididymal fat pads and peri-renal fat. (D)Histological sections of WAT stained with hematoxylin and eosin. (E) Quantitative
analysis of cell numbers per mm2 in the sections of WAT. For each mouse, four random pictures were used. Values are
means – SE of 5 (4 months old) or 9 (20 months old) mice per group. *p< 0.05 vs. WT. WAT, white adipose tissue.
ROLE OF PRX3 IN ADIPOCYTE REGULATION 233
Prx3 deficiency increases mitochondrial oxidative
stress and decreases mitochondrial viability
in 3T3-L1 cells
To evaluate whether the source of ROS are mitochondria
specific, Prx3 knockdown 3T3-L1 adipocytes were loaded
with MitoSOX. Confocal image showed that mitochondrial
superoxide level was significantly increased in Prx3-deficient
3T3-L1 cells (Fig. 6A). Similar results were observed with
DCF-DA implying increased cellular H2O2 in Prx3-deficient
cells (data not shown). Moreover, increased mitochondrial
ROS in Prx3-deficient 3T3-L1 adipocytes were reversed by
treatment of mitochondria-targeted antioxidant MitoQ (Fig.
6B). As shown in Figure 6C, Prx3-overexpressed cells were
protected from H2O2-induced mitochondrial ROS produc-
tion. Moreover, dysfunctional ROS metabolism resulted in
increased protein carbonylation of mitochondrial proteins
isolated from subcutaneous, epididymal, and omental Prx3
KO WAT (Fig. 5E). To determine the effect of Prx3 on mito-
chondrial function, we measured the accumulation of Mito-
Tracker CMXRos, which is dependent on mitochondrial
membrane potential, and citrate synthase activity, a key
component of the TCA cycle. Prx3 knockdown of 3T3-L1
adipocytes showed decreased mitochondrial potential and
citrate synthase activity (Figs. 6D and 6E).
Adipokine levels are impaired in Prx3 KO mice
Data achieved from proteomics and gene expression anal-
ysis imply that Prx3 KO adipocytes may be functionally im-
paired. Since adipokine dysregulation is a hallmark of
adipocyte impairment, we measured adipokine expression in
Prx3 KO adipocytes. Adiponectin mRNA and protein ex-
pression was significantly downregulated and PAI-1 expres-
sion was upregulated in Prx3 KO adipocytes compared toWT
(Figs. 7A–7F). Plasma levels of adiponectin was significantly
decreased in 20-month-old Prx3 KO mice, and PAI-1 was in-
creased in both 4- and 20-month-old Prx3 KO mice but only
FIG. 3. Prx3 deficiency results in increased adipogenic gene expression during adipogenesis. (A) Adipose tissue-derived
stem cells (ASCs) were isolated from subcutaneous fat pads of WT and Prx3 KO mice and differentiated with or without
rosiglitazone. Differentiated cells were stained with Oil Red O and representative pictures were taken. (B) Genes related to
adipogenesis and mitochondrial biogenesis were examined in ASCs from WT and Prx3 KO mice by real-time PCR. Quan-
tifications were normalized to 18S in each reaction. Values are means – SE of six experiments. *p< 0.05 vs. WT ASCs. (C)
Transfection efficiency was validated by reduced Prx3 expression at day 4 after differentiation. There was no change in Prx1
or Prx5 levels by Prx3 siRNA transfection. Western blot analysis of 3T3-L1 cells transfected with (D) Prx3 siRNA or (E) Prx3
vector. 3T3-L1 cells were differentiated 48 h after transfection. Cells were harvested at days 0, 2, and 4 after differentiation.
Scrambled (Scr) siRNA or empty vector was used as transfection control. Tubulin was used as an internal loading control. (To
see this illustration in color, the reader is referred to the web version of this article at www.liebertonline.com/ars).
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had significance at 4-month-old mice. Adipocyte and plasma
leptin levels were not significantly different between two
groups (Figs. 7G–7I).
Metabolic profiles show that Prx3 KO mice are glucose
intolerant and insulin resistant
Increased fat mass, impaired mitochondrial enzymes, and
adipokine dysregulation suggest that deficiency in Prx3 may
result in altered whole bodymetabolism. To assess the impact
of Prx3 on glucose homeostasis, we conducted oral glucose
tolerance test (OGTT). Administration of glucose led to amore
rapid increase of blood glucose in Prx3 KO mice which re-
mained significantly higher throughout the study period (Fig.
8A). Interestingly, loss in Prx3 was effective enough to raise
the fasting glucose level, whereas there was no change in fed
glucose level (Figs. 8C and 8D). Likewise, Prx3 KO mice ex-
hibited significantly decreased sensitivity to insulin as mea-
sured by insulin tolerance test (ITT) with elevated fasting
plasma insulin levels (Figs. 8B and 8E). In addition, plasma
cholesterol was increased in Prx3 KO mice (Fig. 8G). Of note,
decreased pattern of triglycerides (TG) may be explained by
increased level of Lpl mRNA levels in Prx3 KO adipocytes
(Fig. 5A). These results indicate that a mild metabolic dysre-
gulation has occurred in Prx3 KO mice.
Discussion
Our study demonstrated that Prx3 is highly expressed in
mature adipocytes and decreased in obesity. Employing Prx3
FIG. 4. Protein expression profiles of adipocytes obtained from WT and Prx3 KO mice. (A) Representative 2-DE gel
images of WT and Prx3 KO mice adipocytes. Adipocytes isolated from the epididymal fat pads of WT and Prx3 KO mice
were separated on 2D-PAGE (pH 4–7), detected with silver staining, and semi-quantitatively analyzed with image analysis.
Differentially expressed proteins were excised and analyzed by in-gel digestion and UPLC-ESI-q-TOF tandem MS. Identified
protein list is shown in Table 2. (B) Enlarged image of each spot identified by tandem MS.
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Table 2. Differentially Expressed Proteins in Adipocytes of Prx3 KO Mouse
Upregulated Proteins in Prx3 KO Mouse
Spot
No Score
%
Cov.
Queries
Matched Theor.Mr Theor.pI
Accession
No. Symbol Protein Name
Cellular
Component
Proteins that function in metabolism
19 171 19 11 48963 9.11 Q9D2G2 ODO2 Dihydrolipoyllysine-residue
succinyltransferase
component of 2-oxoglutarate
dehydrogenase complex,
mitochondrial
Mito
22 171 28 12 48324 6.19 P29758 OAT Ornithine aminotransferase,
mitochondrial
Mito
Proteins that act in oxido-reduction
20 168 22 7 43069 5.95 Q62465 VAT1 Synaptic vesicle membrane
protein VAT-1 homolog
23, 25 320 31 28 52592 6.52 Q91WD5 NDUS2 NADH dehydrogenase
[ubiquinone] iron-sulfur
protein 2, mitochondrial
Mito
Proteins that function in structural molecules
17 413 10 28 226232 5.54 Q8VDD5 MYH9 Myosin-9
Proteins that act as chaperone/mediators of protein folding
16 739 41 38 80159 6.25 Q9CQN1 TRAP1 Heat shock protein 75 kDa,
mitochondrial
Mito
18 800 52 59 56643 5.88 P27773 PDIA3 Protein disulfide-isomerase
A3
ER
Proteins that act as transporter/channel
21 328 59 39 50505 5.93 Q61598 GDIB Rab GDP dissociation
inhibitor beta
26 655 53 35 15232 4.96 P56395 CYB5 Cytochrome b5
Downregulated Proteins in Prx3 KO Mouse
Proteins that function in metabolism
1 443 17 27 129602 6.25 Q05920 PYC Pyruvate carboxylase,
mitochondrial
Mito
7 1206 27 51 67899 8.81 Q8BMF4 ODP2 Dihydrolipoyllysine-residue
acetyltransferase component
of pyruvate dehydrogenase
complex, mitochondrial
Mito
9 744 63 26 29802 5.57 P67778 PHB Prohibitin Memb, Mito
10 475 19 15 36095 7.6 O35459 ECH1 Delta(3,5)-Delta(2,4)-dienoyl-CoA
isomerase, mitochondrial
Mito
Proteins that act in oxido-reduction
2, 3, 4 380 31 28 79698 5.51 Q91VD9 NDUS1 NADH-ubiquinone oxidoreductase
75 kDa subunit, mitochondrial
Mito
11 425 42 25 35417 8.37 Q99L13 3HIDH 3-hydroxyisobutyrate dehydrogenase,
mitochondrial
Mito
12 257 49 16 27268 7.0 Q9D6J6 NDUV2 NADH dehydrogenase
[ubiquinone] flavoprotein 2,
mitochondrial
Mito
13, 14 82 17 3 28109 7.15 P20108 PRDX3 Thioredoxin-dependent peroxide
reductase, mitochondrial
Mito
Proteins that act as transporter/channel
5, 6 545 36 26 75838 5.34 P14824 ANXA6 Annexin A6 Cyto
8 180 14 5 40578 7.63 Q99LC3 NDUAA NADH dehydrogenase
[ubiquinone] 1 alpha subcomplex
subunit 10, mitochondrial
Mito
15 540 85 26 18738 5.52 Q9DCX2 ATP5H ATP synthase subunit d,
mitochondrial
Mito
Proteins that act as signal transducer
24 419 16 28285 4.8 P61982 1433G 14-3-3 protein gamma Cyto
24 310 18 28069 4.77 Q9CQV8 1433B 14-3-3 protein beta/alpha Cyto
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KO mice and Prx3 knockdown and overexpressed 3T3-L1
cells, we further demonstrated that Prx3 may play a key role
in regulation of mitochondrial ROS and function, adipokine
expression in adipocytes and that Prx3 deficiency leads to
accumulation of WAT and metabolic alteration.
Comparative proteomic analysis allowed detection of
proteins that changed during adipogenesis, some of which
had not been previously reported (Supplementary Fig. S6).
MS/MS analysis combined with 2D-PAGE has the ability to
pick up protein changes that might go undetected by other
approaches. For example, many of the mitochondrial pro-
teins which we have identified escape detection in gel-based
comparative proteomics due to inherent methodological
limitations.
To our knowledge, this is the first study that focused on the
role of endogenous Prx3 in adipocytes. In line with the pre-
vious reports (28–30), Prx3 KO mice exhibit no overt pheno-
type. However, histology showed that adipocytes were
significantly larger in Prx3 KO mice. Hypertrophied adipo-
cytes due to enlarged lipid droplets are frequently observed in
FIG. 5. Prx3 KO mice adipocytes show impaired mitochondrial biogenesis, lipid metabolism, and antioxidant systems.
(A) Genes related to mitochondrial biogenesis, oxidative stress, and lipid metabolism were examined in adipocytes isolated
from WT and Prx3 KO mice by real-time PCR. Quantifications were normalized to 18S in each reaction. (B and C) Im-
munohistochemical analysis of white adipose tissue stained with heat shock protein 60 and nitrotyrosine. Enlarged inset
pictures are shown for better viewing. (D) Plasma lipid peroxidation levels were measured as TBARS concentration in WT
and Prx3 KO mice. (E) Protein carbonylation in mitochondria isolated from WT and Prx3 KO subcutaneous (Subcu), epi-
didymal (Epi), and omental WATs. Values are means – SE of 5 mice per group. *p< 0.05 vs. WT. TBARS, thiobarbituric acid
reactive substances.
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mice models of obesity (17) and these cells exhibit impaired
mitochondrial function and insulin signaling along with
higher ROS levels (10, 18, 33).
The key question is how Prx3 deficiency induces obesity.
We believe that the most plausible mechanism could be the
effect of Prx3 on mitochondrial fitness. Proteomic analysis of
Prx3 KO adipocytes confirmed major changes in mitochon-
drial proteins associated with glucose and lipid metabolism.
Decreased mtDNA levels observed in Prx3 KO mice adipo-
cytes and ASCs further support the defect in mitochondrial
biogenesis. Along with this, significantly decreased mito-
chondrial membrane complex I proteins, including NDUS1
which oxidizes NADH to regenerate NAD+ ; NADH dehy-
drogenase flavoprotein 2 (NDUV2); NADH dehydrogenase 1
alpha subcomplex subunit 10 (NDUAA); NDUS2, NDSU3;
and dihydrolipoyllysine-residue acetyl and succinyltransfer-
ase (ODP2, ODO2) functioning in pyruvate dehydrogenase
complex to convert glycolysis to TCA cycle, were observed.
These results suggest that Prx3 affects mitochondrial complex
I and conversion of glycolysis to TCA cycle. Also, down-
regulation of ATP5H suggests that mitochondrial respiratory
chain may also be disturbed by Prx3 deficiency in adipocytes,
supporting that lack of Prx3 may result in impaired metabo-
lism by accumulating NADH, blocking TCA cycle and then
raising fatty acid synthesis.
Adipocyte mitochondrial dysfunction in Prx3 KO mice is
interconnected with increased mitochondrial ROS. Among
mitochondrial antioxidant enzymes, Prx3 has been estimated
to decompose approximately 90% of hydrogen peroxide
owing to its higher abundance than GPx1 (8), suggesting that
Prx3 has a potential to play a major role in mitochondrial
redox signaling. Increased mitochondrial protein carbonyla-
tion in Prx3 KO mice WAT and increased MitoSOX intensity
in Prx3 knockdown adipocytes substantiate this hypothesis.
Reversal by MitoQ further supports that Prx3 regulates
mitochondrial ROS metabolism. Future studies regarding
in vivo effect of antioxidants such as MitoQ on Prx3 KO mice
are needed.
Imhoff et al. have recently reported that thioredoxin 2
(Trx2), an electron supplier for the catalytic cycle of Prx3,
becomes oxidized in correlation with oxidative mitochondrial
environment during adipogenesis (15). In our setting, oxi-
dized (sulfonic acid) form of Prx3which presumablymoves to
acidic site as shown in MDA-MB231 cell and in WT mouse
adipocytes (Supplementary Figs. S7D and S7E) was not de-
tected in 3T3-L1 adipocytes (Supplementary Figs. S7A and
FIG. 6. Prx3 deficiency in-
creases mitochondrial oxida-
tive stress and decreases
mitochondrial viability in
3T3-L1 cells. (A)Mature 3T3-
L1 adipocytes transfected
with siRNAwere loaded with
5lM MitoSOX, a mitochon-
drial superoxide specific dye
and examined by confocal
microscopy. (B) Transfected
3T3-L1 adipocytes were trea-
ted with or without MitoQ (1
and 5lM) for 1 h before
loading with MitoSOX. De-
cylTPP was used as control
compound. MitoSOX fluores-
cence levels were quantified
by fluorometer. (C) Prx3
overexpressed cells were
treated with 1mM H2O2 for
15min and loaded with Mi-
toSOX. (D) siRNA transfected
3T3-L1 cells were loaded with
100nM MitoTracker Red
CMXRos and examined by
confocal microscopy. (E) Ci-
trate synthase activity was
measured in transfected 3T3-
L1 adipocytes. Values are
means– SE of 3–4 experi-
ments. *p< 0.05 vs. Scr siRNA
or empty vector, {p< 0.05 vs.
Prx3 siRNA or empty vector
treated with H2O2. (To see
this illustration in color, the
reader is referred to the web
version of this article at
www.liebertonline.com/ars).
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S7B). Instead, other post-translational modifications of Prx3,
including modifications at Lys107 to allysine and at Asp84 to
methylester, were identified. It is possible that the redox state
of Trx2 is more sensitive than Prx3 and therefore important in
regulation of Prx3 activity.
As described above, adipogenesis is accompanied by in-
creased ROS levels. However, excessive ROS stimulation in-
creases adipogenicity of adipocytes (25) and use of
antioxidants inhibits adipogenesis (19, 36). Likewise, knock-
down of Prx3 resulted in accelerated adipogenesis with in-
creased lipid metabolism which may result in adipocyte
hypertrophy and reversely in Prx3 overexpressed cells, adi-
pogenic markers were downregulated. Therefore, Prx3 is
needed in ‘normal’ differentiation of adipocytes.
Increased oxidative stress is a major factor that alters adi-
pokine levels in obese or diabetic condition (10, 16). Con-
sistently, loss of Prx3 resulted in decreased adiponectin and
increased PAI-1 expression in adipocytes. It was previously
reported that impaired mitochondrial function sequentially
activates JNK andATF3,mechanisms involved in ER stress, to
decrease adiponectin synthesis (23). Therefore, decreased
mitochondrial vitality and diminished mtDNA in Prx3 KO
adipocytes may explain reduced adiponectin expression.
Impact of Prx3 on mitochondrial ROS and oxidative
phosphorylation might eventually contribute to altered lipid
metabolism in the KO mice. As the main site of cellular en-
ergy, mitochondria generate ATP, NADPH, and substrates
that are essential to synthesize fatty acids from glucose and
other substrates. In adipose tissue, de novo lipogenesis ac-
counts for up to 40% of whole-body lipogenesis, suggesting
the importance of mitochondrial metabolic pathway in reg-
ulation of lipid contents (5). Increased FAS and decreased
MCAD and CPT1a suggest that adipocytes are likely to ac-
cumulate fat in Prx3 KO mice.
Based on our data on adipocytes, it is not difficult to link
our observations with whole body metabolism. Chen et al. (6)
reported that Prx3 overexpressed mice were resistant to diet-
induced elevations in blood glucose, displayed reduced pro-
duction of mitochondrial ROS, and improved glucose ho-
meostasis. Likewise, our results showed that dissipation in
Prx3 influences glucose and insulin homeostasis. We cannot
rule out the possibility of insulin resistance in liver and skel-
etal muscle, which are major sites for glucose metabolism.
Intriguingly, changes in mRNA levels were somewhat dif-
ferent in the liver with only MnSOD being significantly in-
creased (Supplementary Fig. S8), suggesting that the function
FIG. 7. Deficiency in Prx3
results in dysregulation of
adipokines. (A–C) Real-time
PCR analysis of adipocytes
isolated from epididymal
WAT. (D–F) Western blot
analysis of adipocytes iso-
lated from epididymal WAT
and its quantification. (G–I)
Plasma levels of adiponectin,
PAI-1, and leptin were mea-
sured by ELISA in 4- and 20-
month-old WT and Prx3 KO
mice. Values are means – SE
of 5 (4 months old) or 9 (20
months old) mice per group.
*p< 0.05 vs. WT. PAI-1, plas-
minogen activator inhibitor-1.
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of Prx3 might be context dependent. Although partly dem-
onstrated in Prx3 knockdown 3T3-L1 cells, genetic manipu-
lations specific to adipocytes in mice will help assess whether
defects shown here are intrinsic to fat cells or secondary to
functional disturbances in other tissues. Also, Prx3 over-
expression in adipocytes in vitro and in vivo would be inter-
esting to confirm the protective role of Prx3. In our study, Prx3
overexpression has been performed to observe its effect on
adipogenesis and ROS regulation to strengthen the involve-
ment of Prx3 on adipocyte regulation.
Since Prx3 deficiency has been shown to increase the sus-
ceptibility to inflammation or oxidative stress (4, 30), we
recognize that under conditions of metabolic stress such as
high-fat diet, Prx3 KO mice would exhibit a more clear dif-
ference demonstrating the role of Prx3. Body composition
studies and assessment of food intake or energy expenditure
are also needed to understand the protective role of Prx3 in
whole body metabolism. Exploring the role of other Prx iso-
forms such as Prx1 and 2 (cytoplasmic/nucleus) in adipocytes
and obesity would be interesting since cytoplasmic ROS in-
duced by NADPH oxidase still remain to be the major con-
tributor of adipocyte oxidative stress (10). It has been reported
that Prx1 protects against atherosclerosis and Prx2 over-
expression inhibits lipid accumulation during adipogenesis of
mesenchymal stem cells (19), which is similar to our Prx3
overexpression data (Fig. 3E). Prx5, which resides in the mi-
tochondria as well as cytoplasm, may have similar effect on
mitochondrial ROS in adipocytes.
In summary, our data suggest an important biological role
for endogenous Prx3 in regulation of adipocytes. Our efforts
to unravel the complex mechanism of adipogenesis through
proteomics have led to identification of Prx3. Analysis of Prx3
FIG. 8. Prx3 KO mice are
glucose intolerant and insu-
lin insensitive with higher
levels of fasting glucose and
total cholesterol. (A) Oral
glucose tolerance test of WT
and Prx3 KO mice were per-
formed by injecting 2 g glu-
cose per kg body weight after
overnight fasting. (B) Insulin
tolerance test of WT and Prx3
KO mice were performed by
injecting 0.75 IU insulin per
kg body weight after 6 h fast-
ing. (C and D) Glucose levels
of WT and Prx3 KO mice in a
fed and fasted state. (E) Fast-
ing plasma insulin levels of
WT and Prx3 KO mice. (F–H)
Plasma triglyceride, total
cholesterol, and free fatty acid
levels of WT and Prx3 KO
mice. Values are means – SE
of 5 (4 months old) or 9 (20
months old) mice per group.
*p < 0.05 vs. WT.
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KO mice and Prx3 transfected 3T3-L1 cells demonstrated the
critical role of Prx3 in maintaining the function of mature
adipocytes. Although the cause and effect relationships are
yet unknown, this study has provided the first evidence that
defective Prx3 expression in adipose tissue is associated with
reduced antioxidant/mitochondrial function, adipokine
dysregulation, and impaired glucose/insulin homeostasis
(Fig. 9). We propose that Prx3 may play an important role in
the regulation of obesity and metabolic syndrome.
Materials and Methods
Materials and methods for Prx3 KO mice generation, 3T3-
L1 adipocyte culture, proteomic analysis, gene expression
analysis, Western blot analysis, histology, immunohisto-
chemistry, and statistical analysis are described in the Sup-
plementary Methods, available online.
Prx3 KO mice
Male homozygous Prx3 KOmice and their littermates (WT)
were fed a standard chow and water ad libitum. Plasma
cholesterol and TG were assayed at Korea Clinical Labora-
tories (Siheung, Gyeonggi-do, Korea). Plasma free fatty acids,
adiponectin, PAI-1, leptin, and insulin levels were assayed
using commercial kits (from BioAssay Systems, Hayward,
CA; R&D systems, Minneapolis, MN; Innovative Research,
Novi, MI; andMillipore, Billerica, CA, respectively) according
to the manufacturer’s instructions. Plasma levels of TBARS
were measured as a marker of lipid peroxidation as previ-
ously described (12). OGTT and ITT were performed using a
standard protocol (34). All animal studies were conducted in
accordance with protocols approved by the institutional ani-
mal care and use committee of Ewha Womans University.
Isolation of adipocytes and differentiation of ASCs
Adipocytes were isolated from epididymal WAT using the
collagenase method (35) without BSA to avoid interference
during 2D-PAGE. The suspensionwas passed through a sterile
250lm nylon mesh (Nunc, Rochester, NY) and centrifuged at
500 g for 10min. The floating adipocytes were used for mRNA
and protein analysis. ASCs were isolated from the subcutane-
ous WAT, as previously described (22). Differentiation was
induced with DMEM/F-12 containing 10% FBS, 1lM dexa-
methasone, 2lM insulin, and 0.25mM IBMX. Three days later,
medium was changed to DMEM/F-12 containing 5% FBS,
FIG. 9. Suggested model for Prx3 in regulation of adipocytes. Increased Prx3 is associated with normal adipocyte dif-
ferentiation. In Prx3-deficient state, adipogenic genes are upregulated, resulting in abnormally differentiated adipocytes,
possibly due to increased ROS. In mature adipocytes, Prx3 levels are decreased in obese individuals, which results in
accumulation of mitochondrial ROS. This in turn causes defect in mitochondrial function, lipid accumulation, and adipokine
dysregulation. As a result of adipocyte dysregulation, glucose and insulin homeostasis is impaired. Therefore, Prx3 is
necessary in regulation of redox state and metabolism in adipocytes. (To see this illustration in color the reader is referred to
the web version of this article at www.liebertonline.com/ars).
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1lM dexamethasone, and 2lM insulin. Cells were harvested 4
days after induction of differentiation for further analysis.
Fluorescence detection of mitochondrial ROS
and membrane potential
To detect mitochondria specific oxidative stress, mature 3T3-
L1 adipocyteswere loadedwith 5lMMitoSOXRed (Molecular
Probes,Carlsbad, CA) for 10min.Cellswere either examined by
confocal microscopy (LSM 510 META: Carl Zeiss, Thornwood,
NY) or by fluorometer (Molecular Devices, Sunnyvale, CA) at
510nm excitation and 580nm emission. To evaluate the mito-
chondrial membrane potential, 3T3-L1 adipocytes were loaded
with 100nMMitoTracker Red CMXRos (Molecular Probes) for
30min at 37C and examined by confocal microscopy.
Protein carbonylation
Protein carbonylation was detected using DNPH-derivati-
zation method as described previously (27). Briefly, 20lg of
protein lysate was denatured with 12% SDS, and derivatized
with 10mM DNPH solution for 15min. Neutralized samples
were immunoblotted using anti-DNP antibody (Sigma, St.
Louis, MO).
Citrate synthase activity
Citrate synthase activity was measured in 3T3-L1 lysates,
according to instructions provided with the citrate synthase
kit (Sigma).
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Abbreviations Used
3HIDH¼ 3-hydroxyisobutyrate dehydrogenase
ASCs¼ adipose tissue-derived stem cells
ATP5H¼ATP synthase subunit d
BMI¼ body mass index
CPT1a¼ carnitine palmitoyl transferase 1a
ECH1¼dienoyl-CoA isomerase
ER¼ endoplasmic reticulum
FAS¼ fatty acid synthase
GPxs¼ glutathione peroxidases
HO-1¼heme oxygenase-1
HSL¼hormone-sensitive lipase
IBMX¼ 3-isobutyl-1-methylxanthine
ITT¼ insulin tolerance test
KO¼ knockout
Lpl¼ lipoprotein lipase
MCAD¼medium-chain acyl-CoA dehydrogenase
MnSOD¼manganese superoxide dismutase
mtDNA¼mitochondrial DNA
mtTFA¼mitochondrial transcription factor A
NDUS1¼NADH-ubiquinone oxidoreductase
NQO1¼NAD(P)H: quinine oxidoreductase
Nrf 1¼nuclear respiratory factor
Nrf 2¼nuclear factor E2-related factor 2
ODP2¼dihydrolipoyllysine-residue
acetyltransferase component
OGTT¼ oral glucose tolerance test
PAI-1¼plasminogen activator inhibitor-1
PGC1a¼PPARc coactivator-1 alpha
Prx3¼peroxiredoxin 3
ROS¼ reactive oxygen species
TBARS¼ thiobarbituric acid reactive substances
TG¼ triglyceride
Trx2¼ thioredoxin 2
WAT¼white adipose tissue
WT¼wild type
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